Access new treatment options with a breakthrough blood test

For patients with advanced cancers, targeted therapies can provide promising new treatment options. But without a clear genomic picture of your tumor DNA, these therapies are out of reach. Guardant360 provides this picture with a simple blood draw.

Is Guardant360 right for you?

I want to avoid the risks, potential delays, and costs of a surgical biopsy

Guardant Access manages billing

Know your cancer. Help fight all cancer.

Your test may help the overall fight against cancer in ways we have yet to discover.

Every sample we analyze contributes invaluable information to our growing database of tumor alterations and treatment outcomes. We’re drawing a roadmap of the steps cancer may take in response to treatment. The more detail we add to this map, the sooner we can help defeat this disease.

Common Questions

Genomic alterations are changes that occur within the DNA of cancer cells. Some of these changes accelerate the growth of cancer. Some respond well to specific therapies. With a clear picture of the genomic alterations in your tumor, your doctor may be able to recommend a targeted therapy. In general, targeted therapies have fewer side effects than broad-based chemotherapy. They can also be more selective in stopping the spread of a cancer when other treatments have failed.

Some genomic alterations are known to respond better to specific therapies. Guardant360 looks for all these clinically relevant alterations, giving your doctor the opportunity to tailor treatment to your individual cancer.

Today Guardant360 does not predict chemotherapy response, but it does provide information on the genomic alterations known to respond to specific targeted therapies. As cancer research progresses, new response profiles may be identified.